PRS24 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI AND UMEC/VI IN PATIENTS WITH COPD- HEALTHCARE RESOURCE UTILIZATION DATA AND ASSOCIATED COSTS – GERMANY
Abstract
Authors
V. Paly M. Schroeder A. Martin J. Li M. Wacker N. Risebrough S. Lettis A. Ismaila